60% of enterprise firewalls fail initial compliance
The findings, drawn from FireMon's AI-powered FireMon Insights analytics platform, were based on anonymous deployments across large enterprises and regulated industries operating in on-premises, cloud, and hybrid environments. The report identifies widespread misconfigurations, outdated rules, and excessive policy complexity as persistent issues contributing to compliance and security risks.
According to the data, in addition to the 60% failing high-severity checks, a further 34% of firewalls did not meet critical compliance requirements. These compliance shortfalls are not just technical in nature; they indicate deeper governance issues that can contribute to audit failures, operational downtime, and increased vulnerability to cybersecurity threats.
The report also found that 95% of application objects and 82% of service objects within firewall environments showed no usage, thereby increasing unnecessary administrative overhead and broadening the potential attack surface. About 30% of firewall rules were reported as completely unused, while 62.6% lacked ownership or documentation - factors that create audit gaps and operational blind spots. In addition, more than 10% of rules were found to be redundant or shadowed, affecting performance and obscuring potential misconfigurations.
Industry perspectives Organisations have been trying to untangle firewall complexity for years, but too often the tools fall short, either offering static snapshots or failing to provide the operational context that teams actually need. That's why platforms like FireMon Insights matter. They offer a level of clarity and benchmarking that helps teams move from reactive fixes to informed, proactive decisions. FireMon has long been a trusted name in policy management, and it's good to see them pushing the industry forward in this space,
said Mark Miller, Chief Revenue Officer at EncoreCyber.
Jody Brazil, Chief Executive Officer and Founder at FireMon, explained the significance of these findings for security teams dealing with operational complexity. Firewall complexity isn't just a configuration issue, it's a threat to resilience and trust. Security teams are buried under policies they can't explain, map to business objectives, or manage at scale. FireMon Insights cuts through the noise. It benchmarks your performance, exposing what's been missed, and helping you take action before it turns into disruption.
FireMon Insights utilises continuous benchmarking to track compliance key performance indicators and identify misconfigurations in real time, offering always-on visibility across hybrid and multi-vendor infrastructures. This approach is in contrast to legacy tools, which often rely on static scans that may not reflect real-time conditions. FireMon positions its platform as a way for organisations to move from reactive remediation to more proactive governance of network security policies.
Platform enhancements
Recent enhancements to the FireMon Insights platform include device-level metrics grouped by complexity, risk, and environment for greater contextual analysis. Additional features include closer integration with FireMon Policy Manager, an AI-powered natural language search and chatbot to allow users to interact with platform data without specific training, and expanded peer benchmarking so organisations can gauge their position within the industry. FireMon stated that these capabilities are provided at no additional cost to current customers.
Commenting on the adoption of the Insights platform, Brandy Peterson, Chief Technology Officer of Cloud Security Operations, said: Since its initial launch in January 2025, FireMon Insights has quickly become the go-to analytics platform for our customers' security teams. What's been most exciting is the engagement - early adopters across roles are having real 'aha' moments, and their feedback directly shaped this release.
The platform aims to help security teams shift from responding to support tickets to executing more strategic security operations by improving visibility into policy health, benchmarking against peers, and monitoring baseline controls. This supports progress measurement against business objectives and adjustment as required.
Dan Rheault, Director of Product Management at FireMon, addressed broader industry challenges around policy management: Collectively, the cybersecurity industry has been driving organisations to a point of sophistication that actually distracts their cyber strategy from implementing required capabilities and measuring operational outcomes. Teams are turning to FireMon for a smarter, more sustainable path forward.
Rich Mogull, Senior Vice President of Cloud Security at FireMon, explained the value proposition of the Insights platform: Most tools only tell you what happened. Insights tells you what's happening now and more importantly, what to do next. It's not about more alerts. It's about clarity and action, at scale.
Market context
The analysis arrives as security operations continue to demand both speed and accuracy in an environment of increasing policy complexity and compliance requirements. FireMon reports ongoing momentum with the recognition of FireMon Insights as a finalist in a recent technology award and recent appointments to the company's leadership team to support continued expansion and operational focus.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Reaction to South Korea's trade deal with Trump
SEOUL (Reuters) -South Korea and the United States said they reached a deal that would set U.S. tariffs on most South Korean goods at 15% in return for $350 billion in investment in the U.S. Officials, analysts, and companies in Seoul said the deal removed uncertainty. Here are some key quotes. KATHLEEN OH, CHIEF KOREA ECONOMIST AT MORGAN STANLEY 'Our initial take is that it is a case of the worst avoided, with a pinch of relief removing Korea-specific tariff risks. We also see this as broadly positive, as it puts Korea on level ground with its export competitors in the U.S., especially for autos. "Now that the trade deal uncertainty is removed, the BoK will revise its growth forecast higher on the latest stimulus package. We believe continued stabilisation in the housing market trend now holds (the) key before we see the next cut in August.' HYUNDAI MOTOR GROUP STATEMENT "For Hyundai Motor Group, this agreement validates our unwavering confidence in the U.S. market and our commitment to American manufacturing. Our $21 billion investment plan through 2028 – building upon our existing $20.5 billion commitment – represents one of the largest foreign investments in American automotive history. Our U.S. investments will create more than 100,000 direct and indirect jobs, supporting 570,000 American jobs. This agreement ensures we can continue scaling these commitments with confidence." SAMSUNG ELECTRONICS CHIEF FINANCIAL OFFICER PARK SOON-CHEOL 'We believe that the uncertainty has been reduced through the conclusion of negotiations between the United States and South Korea. We are closely monitoring the follow-up discussions between the two governments regarding the detailed contents of the recently announced agreement, and we plan to formulate our response strategy accordingly." CHEONG IN-KYO, SOUTH KOREA'S FORMER TRADE MINISTER "We avoided the worst and chose the second best; 15% was in line with expectations. But when talking about investments, what was promised is going to be very important. Depending on how and where $350 billion will be spent, this fund will be looked at differently. If that money only flows into the U.S. or supports South Korean companies' investments there. If that's about South Korean companies' investment, that can be helpful in a way that South Korean companies can fill the vacuum by going into the U.S. while China is moving out, when the U.S. is reforming its manufacturing." KIM GUNN, SOUTH KOREAN FORMER DIPLOMAT AND CURRENT OPPOSITION LAWMAKER "If the agreement was reached on equal terms compared to our competitors, it is a bit of a relief. At the very least, our companies will be able to compete in the U.S. market, but the devil is in the details, isn't it? So details are going to be far more important. For now, President Trump is able to boast about the deal domestically. We need to look into the details to see if we've made excessive concessions." Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 minutes ago
- Yahoo
‘Just a jumble of bones.' How a baby grave discovery has grown to haunt Ireland
Ireland Baby Mass Graves TUAM, Ireland (AP) — This story begins with a forbidden fruit. It was the 1970s in this small town in the west of Ireland when an orchard owner chased off two boys stealing his apples. The youngsters avoided being caught by clambering over the stone wall of the derelict Bon Secours Mother and Baby Home. When they landed, they discovered a dark secret that has grown to haunt Ireland. One of the boys, Franny Hopkins, remembers the hollow sound as his feet hit the ground. He and Barry Sweeney pushed back some briars to reveal a concrete slab they pried open. 'There was just a jumble of bones,' Hopkins said. 'We didn't know if we'd found a treasure or a nightmare.' Hopkins didn't realize they'd found a mass unmarked baby grave in a former septic tank — in a town whose name is derived from the Irish word meaning burial place. It took four decades and a persistent local historian to unearth a more troubling truth that led this month to the start of an excavation that could exhume the remains of almost 800 infants and young children. The Tuam grave has compelled a broader reckoning that extends to the highest levels of government in Dublin and the Vatican. Ireland and the Catholic Church, once central to its identity, are grappling with the legacy of ostracizing unmarried women who they believed committed a mortal sin and separating them from children left at the mercy of a cruel system. An unlikely investigator Word of Hopkins' discovery may never have traveled beyond what is left of the home's walls if not for the work of Catherine Corless, a homemaker with an interest in history. Corless, who grew up in town and vividly remembers children from the home being shunned at school, set out to write an article about the site for the local historical society. But she soon found herself chasing ghosts of lost children. 'I thought I was doing a nice story about orphans and all that, and the more I dug, the worse it was getting,' she said. Mother and baby homes were not unique to Ireland, but the church's influence on social values magnified the stigma on women and girls who became pregnant outside marriage. The homes were opened in the 1920s after Ireland won its independence from Britain. Most were run by Catholic nuns. In Tuam's case, the mother and baby home opened in a former workhouse built in the 1840s for poor Irish where many famine victims died. It had been taken over by British troops during the Irish Civil War of 1922-23. Six members of an Irish Republican Army faction that opposed the treaty ending the war were executed there in 1923. Two years later, the imposing three-story gray buildings on the outskirts of town reopened as a home for expectant and young mothers and orphans. It was run for County Galway by the Bon Secours Sisters, a Catholic order of nuns. The buildings were primitive, poorly heated with running water only in the kitchen and maternity ward. Large dormitories housed upward of 200 children and 100 mothers at a time. Corless found a dearth of information in her local library but was horrified to learn that women banished by their families were essentially incarcerated there. They worked for up to a year before being cast out — most of them forever separated from their children. So deep was the shame of being pregnant outside marriage that women were often brought there surreptitiously. Peter Mulryan, who grew up in the home, learned decades later that his mother was six months pregnant when she was taken by bicycle from her home under the cover of darkness. The local priest arranged it after telling her father she was 'causing a scandal in the parish.' Mothers and their children carried that stigma most of their lives. But there was no accountability for the men who got them pregnant, whether by romantic encounter, rape or incest. More shocking, though, was the high number of deaths Corless found. When she searched the local cemetery for a plot for the home's babies, she found nothing. Long-lost brothers Around the time Corless was unearthing the sad history, Anna Corrigan was in Dublin discovering a secret of her own. Corrigan, raised as an only child, vaguely remembered a time as a girl when her uncle was angry at her mother and blurted out that she had given birth to two sons. To this day, she's unsure if it's a memory or dream. While researching her late father's traumatic childhood confined in an industrial school for abandoned, orphaned or troubled children, she asked a woman helping her for any records about her deceased mom. Corrigan was devastated when she got the news: before she was born, her mother had two boys in the Tuam home. 'I cried for brothers I didn't know, because now I had siblings, but I never knew them,' she said. Her mother never spoke a word about it. A 1947 inspection record provided insights to a crowded and deadly environment. Twelve of 31 infants in a nursery were emaciated. Other children were described as 'delicate,' 'wasted,' or with 'wizened limbs.' Corrigan's brother, John Dolan, weighed almost 9 pounds when he was born but was described as 'a miserable, emaciated child with voracious appetite and no control over his bodily functions, probably mental defective.' He died two months later in a measles outbreak. Despite a high death rate, the report said infants were well cared for and diets were excellent. Corrigan's brother, William, was born in May 1950 and listed as dying about eight months later. There was no death certificate, though, and his date of birth was altered on the ledger, which was sometimes done to mask adoptions, Corrigan said. Ireland was very poor at the time and infant mortality rates were high. Some 9,000 babies — or 15% — died in 18 mother and baby homes that were open as late as 1998, a government commission found. In the 1930s and 1940s, more than 40% of children died some years in the homes before their first birthday. Tuam recorded the highest death percentage before closing in 1961. Nearly a third of the children died there. In a hunt for graves, the cemetery caretaker led Corless across the street to the neighborhood and playground where the home once stood. A well-tended garden with flowers, a grotto and Virgin Mary statue was walled off in the corner. It was created by a couple living next door to memorialize the place Hopkins found the bones. Some were thought to be famine remains. But that was before Corless discovered the garden sat atop the septic tank installed after the famine. She wondered if the nuns had used the tank as a convenient burial place after it went out of service in 1937, hidden behind the home's 10-foot-high walls. 'It saved them admitting that so, so many babies were dying,' she said. 'Nobody knew what they were doing.' A sensational story When she published her article in the Journal of the Old Tuam Society in 2012, she braced for outrage. Instead, she heard almost nothing. That changed, though, after Corrigan, who had been busy pursuing records and contacting officials from the prime minister to the police, found Corless. Corrigan connected her with journalist Alison O'Reilly and the international media took notice after her May 25, 2014, article on the Sunday front page of the Irish Mail with the headline: 'A Mass Grave of 800 Babies.' The article caused a firestorm, followed by some blowback. Some news outlets, including The Associated Press, highlighted sensational reporting and questioned whether a septic tank could have been used as a grave. The Bon Secours sisters hired public relations consultant Terry Prone, who tried to steer journalists away. 'If you come here you'll find no mass grave,' she said in an email to a French TV company. 'No evidence that children were ever so buried and a local police force casting their eyes to heaven and saying, 'Yeah a few bones were found — but this was an area where famine victims were buried. So?'' Despite the doubters, there was widespread outrage. Corless was inundated by people looking for relatives on the list of 796 deaths she compiled. Those reared with the stain of being 'illegitimate' found their voice. Mulryan, who lived in the home until he was 4½, spoke about being abused as a foster child working on a farm, shoeless for much of the year, barely schooled, underfed and starved for kindness. 'We were afraid to open our mouths, you know, we were told to mind our own business,' Mulryan said. 'It's a disgrace. This church and the state had so much power, they could do what they liked and there was nobody to question them.' Then-Prime Minister Enda Kenny said the children were treated as an 'inferior subspecies' as he announced an investigation into mother and baby homes. When a test excavation confirmed in 2017 that skeletons of babies and toddlers were in the old septic tank, Kenny dubbed it a 'chamber of horrors.' Pope Francis acknowledged the scandal during his 2018 visit to Ireland when he apologized for church 'crimes' that included child abuse and forcing unmarried mothers to give up their children. It took five years before the government probe primarily blamed the children's fathers and women's families in its expansive 2021 report. The state and churches played a supporting role in the harsh treatment, but it noted the institutions, despite their failings, provided a refuge when families would not. Some survivors saw the report as a damning vindication while others branded it a whitewash. Prime Minister Micheál Martin apologized, saying mothers and children paid a terrible price for the nation's 'perverse religious morality.' 'The shame was not theirs — it was ours,' Martin said. The Bon Secours sisters offered a profound apology and acknowledged children were disrespectfully buried. 'We failed to respect the inherent dignity of the women and children,' Sister Eileen O'Connor said. 'We failed to offer them the compassion that they so badly needed.' The dig When a crew including forensic scientists and archaeologists began digging at the site two weeks ago, Corless was 'on a different planet,' amazed the work was underway after so many years. It is expected to take two years to collect bones, many of which are commingled, sort them and use DNA to try to identify them with relatives like Corrigan. Dig director Daniel MacSweeney, who previously worked for the International Committee of Red Cross to identify missing persons in conflict zones in Afghanistan and Lebanon, said it is a uniquely difficult undertaking. 'We cannot underestimate the complexity of the task before us, the challenging nature of the site as you will see, the age of the remains, the location of the burials, the dearth of information about these children and their lives,' MacSweeney said. Nearly 100 people, some from the U.S., Britain, Australia, and Canada, have either provided DNA or contacted them about doing so. Some people in town believe the remains should be left undisturbed. Patrick McDonagh, who grew up in the neighborhood, said a priest had blessed the ground after Hopkins' discovery and Masses were held there regularly. 'It should be left as it is,' McDonagh said. 'It was always a graveyard.' A week before ground was broken, a bus delivered a group of the home's aging survivors and relatives of mothers who toiled there to the neighborhood of rowhouses that ring the playground and memorial garden. A passageway between two homes led them through a gate in metal fencing erected to hide the site that has taken on an industrial look. Beyond grass where children once played — and beneath which children may be buried — were storage containers, a dumpster and an excavator poised for digging. It would be their last chance to see it before it's torn up and — maybe — the bones of their kin recovered so they can be properly buried. Corrigan, who likes to say that justice delayed Irish-style is 'delay, deny 'til we all go home and die,' hopes each child is found. 'They were denied dignity in life, and they were denied dignity and respect in death,' she said. 'So we're hoping that today maybe will be the start of hearing them because I think they've been crying for an awful long time to be heard.' ___ Associated Press religion coverage receives support through the AP's collaboration with The Conversation US, with funding from Lilly Endowment Inc. The AP is solely responsible for this content.
Yahoo
6 minutes ago
- Yahoo
Ipsen delivers strong results in the first half of 2025 and upgrades its full-year guidance
H1 total sales growth of 11.4% at CER1, or 9.7% as reported, driven by the three therapeutic areas: 95.7% in Rare Disease, 9.7% in Neuroscience, and 6.4% in Oncology H1 core operating income of €656m, growing by 21.9% as reported, with a core operating margin of 36.0% of total sales, increasing by 3.6 points Upgraded FY 2025 financial guidance2: total-sales growth greater than 7.0% at CER (prior guidance: greater than 5.0% at CER); core operating margin greater than 32.0% of total sales (prior guidance: greater than 30%) Pipeline progression including regulatory filing of tovorafenib in Europe, and initiation of a Phase II trial of LANT3 (IPN10200) in cervical dystonia European Commission approval on 23 July 2025 of Cabometyx® in advanced neuroendocrine tumors (NETs), the sixth indication Key upcoming milestones with the pivotal FALKON trial results for fidrisertib in FOP4 and the Proof-of-Concept data readout for the LANT in aesthetics PARIS, FRANCE, 31 July 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-carebiopharmaceutical company, today presents its financial results for the first half of 2025. Extract of consolidated results H1 2025 H1 2024 % change €m €m Actual CERTotal Sales 1,819.8 1,659.3 9.7% 11,4 % Core Operating Income 655.8 538.0 21.9%Core operating margin 36.0% 32.4% +3.6ptsCore Consolidated Net Profit 508.3 399.4 27.3%Core earnings per share (fully diluted) €6.07 €4.78 27.0%IFRS Operating Income 451.6 317.8 42.1%IFRS operating margin 24.8% 19.2% +5.7ptsIFRS Consolidated Net Profit 335.5 232.3 44.4%IFRS earnings per share (fully diluted) €4.00 €2.78 44.0%Free Cash Flow 483.2 393.5 22.8%Closing Net cash / (Debt) 487.6 (6.8) n/a'Our half year results reflect continued strong momentum, with growth across all three therapeutic areas, particularly in our rare liver disease franchise, which is expanding rapidly and progressing well,' said David Loew, Chief Executive Officer, Ipsen. 'Building on that performance, I am pleased to increase our full year guidance in terms of sales and profitability.' 'I'm also delighted to report robust progression in our pipeline and portfolio, including the recent European Commission approval of Cabometyx® in advanced neuroendocrine tumors, an area where Ipsen has a strong legacy. In the second half of the year, we are anticipating the readout of our pivotal study of fidrisertib in fibrodysplasia ossificans progressiva and the proof-of-concept trial of our long-acting neurotoxin in aesthetics. Our focused strategy, our culture of excellence in execution and our commitment to science with purpose position us to provide a positive impact for patients and society.' Full-year 2025 guidance Based on the strong performance in the first half, Ipsen upgrades its financial guidance for 2025: Total-sales growth greater than 7.0%, at CER. Based on the average level of exchange rates in June 2025, an adverse impact on total sales of around 2% from currencies is expected Core operating margin greater than 32.0% of total sales, which includes additional R&D expenses from anticipated early and mid-stage external-innovation opportunities Guidance includes a negative impact on Somatuline sales due to a potential increased generic competition in the U.S. and Europe. It excludes any impact from potential late-stage (Phase III clinical development or later) business development transactions. Pipeline update since Q1 2025 In May 2025, Ipsen presented data on Iqirvo® (elafibranor) from the Phase II ELMWOOD study at the European Association for the Study of the Liver congress. It showed a favorable safety profile and demonstrated dose-dependent efficacy over 12 weeks for people living with PSC5, a rare liver disease with no approved treatment options. In June 2025, Ipsen initiated a Phase II study of LANT (IPN10200), in cervical dystonia. This marked the fourth study in the global long-acting neurotoxin development plan in therapeutics and aesthetics indications. On 23 July 2025, Ipsen received European Commission approval for Cabometyx® (cabozantinib) in previously treated advanced neuroendocrine tumors. This approval was based on positive outcomes from the Phase III CABINET trial. Consolidated financial statements The Board of Directors approved the condensed consolidated financial statements on 30 July 2025. The Company's auditors performed a limited review of the H1 2025 condensed consolidated financial statements. The interim financial report, with regards to the regulated information, will be available on in due course, under the Reports and Accounts tab in the Investor Relations section. Conference call A conference call and webcast for investors and analysts will begin today at 1pm CET. Participants can access the call and its details by registering here; webcast details can be found here. Calendar Ipsen intends to publish its year-to-date and third-quarter sales update on 22 October 2025. Notes All financial figures are in € millions (€m). The performance shown in this announcement covers the six-month period to 30 June 2025 (H1 2025) and the three-month period to 30 June 2025 (Q2 2025), compared to the six-month period to 30 June 2024 (H1 2024) and the three-month period to 30 June 2024 (H1 2024), respectively, unless stated otherwise. Commentary is based on the performance in H1 2025, unless stated IPSEN We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in more than 80 countries. Ipsen is listed in Paris (Euronext: IPN) and in the U.S. through a Sponsored Level I American Depositary Receipt program (ADR: IPSEY). For more information, visit CONTACTS Khalid Deojee +33 6 66 01 95 26 Sally Bain +1 857 32 00 517Anne Liontas +33 7 67 34 72 96 1 At constant exchange rates (CER), which exclude any foreign-exchange impact by recalculating the performance for the relevant period by applying the exchange rates used for the prior period.2 Excluding any impact from potential late-stage (Phase III clinical development or later) external-innovation transactions.3 Long-acting neurotoxin.4 Fibrodysplasia ossificans progressiva.5 Primary sclerosing cholangitis Attachment Ipsen - H1 2025 results announcementSign in to access your portfolio
